Overview of Citalo
| Property | Description |
|---|---|
| Active ingredient | Escitalopram (typically as the oxalate salt) |
| Form | Film-coated tablet and oral solution |
| Pharmacological class | Selective Serotonin Reuptake Inhibitor (SSRI) |
| Common purpose | Aiding in the stabilization of mood and reduction of excessive worry |
| Origin | Synthetic compound (pure S-enantiomer) |
1. What Type of Medication is Citalo? (Identity and Classification)
Citalo is a specific pharmaceutical preparation containing the active ingredient Escitalopram, which places it within the drug class known as Selective Serotonin Reuptake Inhibitors (SSRIs). This class is primarily utilized as an antidepressant, and its efficacy is clinically recognized for managing conditions involving persistent negative emotional states and severe anxiety. The designation "selective" confirms that Escitalopram is specifically engineered to target and modulate the activity of the neurotransmitter serotonin, exhibiting minimal effect on other brain chemical messengers. The medication is a prescription-only item, underscoring the necessity of medical supervision for its use.
2. Composition, Origin, and Form (Substance and Origin Intents)
The core substance, Escitalopram, is a fully synthetic compound, manufactured as the oxalate salt. It is chemically significant as the purified S-enantiomer—or single isomer—of the related compound citalopram. Escitalopram is the active S-enantiomer, a key differentiating factor that focuses the drug's activity on the most therapeutically potent molecular structure. Citalo is prepared for oral administration and is supplied primarily as a film-coated tablet or, less commonly, as an oral solution, providing flexibility for specific patient groups, such as those who have difficulty swallowing tablets.
3. General Purpose of this SSRI (High-Level Benefit Intents)
The overall purpose of Citalo is to promote a beneficial shift in the brain's neurochemical environment by augmenting the action of serotonin. This is achieved by the drug's mechanism of inhibiting the reabsorption (reuptake) of serotonin by nerve cells. This sustained action on serotonergic activity is the core principle that allows the medication to aid in the gradual restoration of stable neurochemical balance. For patients, the general use scenario involves mitigating symptoms such as pervasive sadness or continuous, uncontrollable worry, thereby stabilizing overall emotional function.
Regulatory References
